Lisa Peraza
2021
In 2021, Lisa Peraza earned a total compensation of $796.8K as Vice President, Chief Accounting Officer at Heron Therapeutics, a 50% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $118,965 |
|---|---|
| Option Awards | $75,530 |
| Salary | $339,900 |
| Stock Awards | $247,123 |
| Other | $15,237 |
| Total | $796,755 |
Peraza received $339.9K in salary, accounting for 43% of the total pay in 2021.
Peraza also received $119K in non-equity incentive plan, $75.5K in option awards, $247.1K in stock awards and $15.2K in other compensation.
Rankings
In 2021, Lisa Peraza's compensation ranked 9,490th out of 12,415 executives tracked by ExecPay. In other words, Peraza earned more than 23.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,490 out of 12,415 | 24th |
Division Manufacturing | 4,207 out of 5,505 | 24th |
Major group Chemicals And Allied Products | 1,863 out of 2,375 | 22nd |
Industry group Drugs | 1,652 out of 2,096 | 21st |
Industry Pharmaceutical Preparations | 1,228 out of 1,546 | 21st |
Pay ratio
| Lisa Peraza's Pay | $796,755 |
|---|---|
| Median Employee's Pay | $268,692 |
| Pay Ratio | 3to 1 |
In 2021, the annual total compensation of Lisa Peraza was $796,755.
The annual total compensation of the median employee at Heron Therapeutics was $268,692.
The ratio of Lisa Peraza's pay to the pay of median employee was therefore 3 to one.
Source: SEC filing on April 25, 2022.
Peraza's colleagues
We found four more compensation records of executives who worked with Lisa Peraza at Heron Therapeutics in 2021.